Macrophage differentiation in enhancing hematopoietic function of ribonucleic acid for injection II via multi-omics analysis
Ribonucleic acid for injection II is a clinical adjuvant cancer therapy treatment based on immunotherapy, which exerts its effects by enhancing immune function and suppressing tumor growth. However, the mechanism underlying the ameliorative effect on immunosuppressed hematopoietic dysfunction remain...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
Compuscript Ltd
2024-07-01
|
| Sraith: | Acta Materia Medica |
| Rochtain ar líne: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0001 |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|